Mechanism of action of and resistance to quinolones

Microbial Biotechnology

Volumn 2, Issue 1, 2009, Pages 40-61

  Fàbrega, Anna ^a   Madurga, Sergi ^a,b   Giralt, Ernest ^a,b   Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ASPARAGINE; ASPARTIC ACID; BACTERIAL DNA; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; DNA TOPOISOMERASE IV; ENVELOPE PROTEIN; ERYTHROMYCIN; GLUTAMINE; GLYCINE; LEUCINE; MEMBRANE FUSION PROTEIN; NALIDIXIC ACID; PENTAPEPTIDE; PHENYLALANINE; PIPERAZINE; PORIN; PROTEIN PARC; PROTEIN PARE; QUINOLONE DERIVATIVE; RIFAMPICIN; SERINE; TETRACYCLINE; TYROSINE; UNINDEXED DRUG; VALINE;

ACINETOBACTER BAUMANNII; ALPHA CHAIN; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL VIABILITY; BETA CHAIN; CAMPYLOBACTER JEJUNI; CHROMOSOME MUTATION; CODON; CORYNEBACTERIUM; DNA SYNTHESIS INHIBITION; DRUG ACCUMULATION; DRUG PENETRATION; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GRAM POSITIVE BACTERIUM; HELICOBACTER PYLORI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PLASMID; PROTEIN FAMILY; PROTEIN TARGETING; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; UPREGULATION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; PROTEIN BINDING; QUINOLONES;

EID: 70349747465     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/j.1751-7915.2008.00063.x     Document Type: Review

References (200)

1. Abouzeed, Y.M., Baucheron, S., and Cloeckaert, A. (2008) ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 52: 2428-2434. (Pubitemid 351915672)
2. Akiba, M., Lin, J., Barton, Y.W., and Zhang, Q. (2006) Interaction of CmeABC and CmeDEF in conferring anti-microbial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother 57: 52-60. (Pubitemid 43057059)
3. Ali, J.A., Jackson, A.P., Howells, A.J., and Maxwell, A. (1993) The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry 32: 2717-2724. (Pubitemid 23090662)
4. Ali, J.A., Orphanides, G., and Maxwell, A. (1995) Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein. Biochemistry 34: 9801-9808.
5. Alonso, A., and Martínez, J.L. (2000) Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44: 3079-3086. (Pubitemid 30803069)
6. Alonso, A., and Martínez, J.L. (2001) Expression of multidrug efflux pump smeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 45: 1879-1881. (Pubitemid 32466365)
7. Amabile, C.F., and Demple, B. (1991) Molecular characterization of the soxRS genes of Escherichia coli: two genes control a superoxide stress regulon. Nucleic Acids Res 19: 4479-4484. (Pubitemid 21912827)
8. Ariza, R.R., Li, Z., Ringstad, N., and Demple, B. (1995) Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol 177: 1655-1661.
9. Arsène, S., and Leclerg, R. (2007) Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones. Antimicrob Agents Chemother 51: 3254-3258. (Pubitemid 350067537)
10. Avrain, L., Garvey, M., Mesaros, N., Glupczynski, Y., Mingeot-Leclerq, M.P., Piddock, L.J.V., et al. (2007) Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. J Antimicrob Chemother 60: 965-972. (Pubitemid 47617741)
11. Ball, P. (1998) The quinolones: history and overview. In The Quinolones, 2nd edn. Andriole, V.T. (ed.). San Diego, CA, USA: Academic Press, pp. 1-28.
12. Ball, P. (2000) Quinolone generations: natural history or natural selection? J Antimicrob Chemother 46: 17-24. (Pubitemid 30468444)
13. Ball, P., Fernald, A., and Tillotson, G. (1998) Therapeutic advances of new fluoroquinolones. Exp Opin Invest Drugs 7: 761-783.
14. Balsalobre, L., Ferrándiz, M.J., Liñares, J., Tubau, F., and de la Camoa, A.G. (2003) Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother 47: 2072-2081. (Pubitemid 36753553)
15. Barrett, J.F. (2000) Moxifloxacin Bayer. Curr Opin Invest Drugs 1: 45-51.
16. Baucheron, S., Tyler, S., Boyd, D., Mulvey, M.R., Chaslus-Dancla, E., and Cloeckaert, A. (2004) AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob Agents Chemother 48: 3729-3735. (Pubitemid 39304596)
17. Bhavnani, S.M., and Ballow, C.H. (2000) New agents for Gram-positive bacteria. Curr Opin Microbiol 3: 528-534.
18. Boehm, H.J., Boehringer, M., Bur, D., Gmuender, H., Huber, W., Klaus, W., et al. (2000) Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J Med Chem 43: 2664-2674. (Pubitemid 30463915)
19. de la Campa, A.G., Balsalobre, L., Ardanuy, C., Fenoll, A., Pérez-Trallero, E., and Liñares, J. (2004) Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain. Emerg Infect Dis 10: 1751-1759. (Pubitemid 39319365)
20. Cao, L., Srikumar, R., and Poole, K. (2004) MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol Microbiol 53: 1423-1436. (Pubitemid 39209115)
21. Cattoir, V., Poirel, L., Aubert, C., Soussy, C.J., and Nordman, P. (2008) Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerg Infect Dis 14: 231-237. (Pubitemid 351213672)
22. Champoux, J.J. (2001) DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70: 369-413. (Pubitemid 32662215)
23. Chang, L.L., Chen, H.F., Chang, C.Y., Lee, T.M., and Wu, W.J. (2004) Contribution of integrons, SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 53: 518-521. (Pubitemid 38380253)
24. Chen, S., Zhang, A., Blyn, L.B., and Storz, G. (2004) MicC, a second small-RNA regulator of Omp protein expression in Escherichia coli. J Bacteriol 186: 6689-6697. (Pubitemid 39332105)
25. Chen, S., Cui, S., McDermott, P.F., Zhao, S., White, D.G., Paulsen, I., and Meng, J. (2007) Contribution of target gene mutations and efflux to decreased susceptibility of Samonella enterica serovar Typhimurium to fluoroquinolones and other antimicrobials. Antimicrob Agents Chemother 51: 535-542. (Pubitemid 46185271)
26. Chenia, H.Y., Pillay, B., and Pillay, D. (2006) Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J Antimicrob Chemother 58: 1274-1278. (Pubitemid 44884152)
27. Cheung, T.K., Chu, Y.W., Chu, M.Y., Ma, C.H., Yung, R.W., and Kam, K.M. (2005) Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype enteritidis in Hong Kong. J Antimicrob Chemother 56: 586-589. (Pubitemid 41264141)
28. Chou, J.H., Greenberg, J.T., and Demple, B. (1993) Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus. J Bacteriol 175: 1026-1031. (Pubitemid 23060137)
29. Chu, C., Su, L.H., Chu, C.H., Baucheron, S., Cloeckaert, A., and Chiu, C.H. (2005) Resistance to fluoroquinolones linked to gyrA and parC mutations and overexpression of acrAB efflux pump in Salmonella enterica serotype Choleraesuis. Microb Drug Resist 11: 248-253. (Pubitemid 41434169)
30. Chu, D.T.W. (1996) The future role of quinolones. Exp Opin Ther Patents 6: 711-737.
31. Chuanchuen, R., Narasaki, C.T., and Schweizer, H.P. (2002) The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J Bacteriol 184: 5036-5044. (Pubitemid 34971028)
32. Cohen, S.P., McMurray, L.M., and Levy, S.B. (1988) marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol 170: 5416-5422. (Pubitemid 19004356)
33. Cohen, S.P., McMurray, L.M., Hooper, D.C., Wolfson, J.S., and Levy, S.B. (1989) Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 33: 1318-1325. (Pubitemid 19191979)
34. Corbett, K.D., and Berger, J.M. (2004) Structure, molecular mechanisms and evolutionary relationships in DNA topoisomerases. Annu Rev Biophys Biomol Struct 33: 95-118. (Pubitemid 38829953)
35. Corbett, K.D., Shultzaberger, R.K., and Berger, J.M. (2004) The C-terminal domain of DNA gyrase A adopts a DNA-bending beta-pinwheel fold. Proc Natl Acad Sci USA 101: 7293-7298. (Pubitemid 38638026)
36. Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., and Courvalin, P. (2008) AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother 52: 557-562. (Pubitemid 351170828)
37. Deguchi, T., Kawamura, T., Yasuda, M., Nakano, M., Fukuda, H., Kato, H., et al. (1997) In vivo selection of Klebsiella peumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob Agents Chemother 41: 1609-1611. (Pubitemid 27289699)
38. DeMarco, C.E., Cushing, L.A., Frempong-Manso, E., Seo, S.M., Jaravaza, T.A.A., and Kaatz, G.W. (2007) Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 51: 3235-3239. (Pubitemid 350067534)
39. Drlica, K., and Zhao, X. (1997) DNAgyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61: 377-392.
40. Edgar, R., and Bibi, E. (1997) MdfA, an Escherichia coli multidrug resistance protein with an extraordinary broad spectrum of drug recognition. J Bacteriol 179: 2274-2280. (Pubitemid 27146882)
41. Fèbrega, A., Sánchez-Céspedes, J., Soto, S., and Vila, J. (2008) Quinolone resistance in the food chain. Int J Antimicrob Agents 31: 307-315.
42. Ferrándiz, M.J., Fenoll, A., Liñares, J., and de la Campa, A.G. (2000) Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 44: 840-847. (Pubitemid 30165258)
43. Fournier, B., Aras, R., and Hooper, D.C. (2000) Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system. J Bacteriol 182: 664-671. (Pubitemid 30053996)
44. Fournier, B., Truong-Bolduc, Q.C., Zhang, X., and Hooper, D.C. (2001) A mutation in the 5′ untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J Bacteriol 183: 2367-2371. (Pubitemid 32240409)
45. Gallegos, M.T., Schleif, R., Bairoch, A., Hofmann, K., and Ramos, J.L. (1997) AraC/XylS family of transcriptional regulators. Microbiol Mol Biol Rev 61: 393-410.
46. Garvey, M.I., and Piddock, L.J.V. (2008) The efflux pump inhibitor reserpine selects multidrug resistant Streptococcus pneumoniae that over-express the ABC transporters PatA and PatB. Antimicrob Agents Chemother 52: 1677-1685. (Pubitemid 351614660)
47. Ge, B., McDermott, P.F., White, D.G., and Meng, J. (2005) Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 49: 3347-3354. (Pubitemid 41060581)
48. Gellert, M., Mizuuchi, K., O'Dea, M.H., and Nash, H.A. (1976) DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci USA 73: 3872-3876.
49. George, A.M., Hall, R.M., and Stokes, H.W. (1995) Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 141: 1909-1920.
50. Gill, M.J., Brenwald, N.P., and Wise, R. (1999) Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 43: 187-189. (Pubitemid 29069226)
51. Hasdemir, U.O., Chevalier, J., Nordmann, P., and Pagès, J.M. (2004) Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microb 42: 2701-2706. (Pubitemid 38747524)
52. Hata, M., Suzuki, M., Matsumoto, M., Takahashi, M., Sato, K., Ibe, S., and Sakae, K. (2005) Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 49: 801-803. (Pubitemid 40175702)
53. Henrichfreise, B., Wiegand, I., Pfister, W., and Wiedemann, B. (2007) Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother 51: 4062-4070. (Pubitemid 350057805)
54. Hernández-Allés, S., Conejo, M.C., Pascula, A., Tomás, J.M., Benedí, V.J., and Martínez-Martínez, L. (2000) Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother 46: 273-277. (Pubitemid 30639298)
55. Hiasa, H. (2002) The Glu-84 of the parC subunit plays critical roles in both Topoisomerase IV-quinolone and Topoisomerase IV-DNA interactions. Biochemistry 41: 11779-11785.
56. Hiasa, H., and Shea, M.E. (2000) DNA gyrase-mediated wrapping of the DNA strand is required for the replication fork arrest by the DNA gyrase-quinolone-DNA ternary complex. J Biol Chem 275: 34780-34786. (Pubitemid 30819258)
57. Higgins, N.P., Peebles, C.L., Sugino, A., and Cozzarelli, N.R. (1978) Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity. Proc Natl Acad Sci USA 75: 1773-1777. (Pubitemid 8344395)
58. Higgins, P.G., Fluit, A.C., Milatovic, D., Verhoef, J., and Schmitz, F.J. (2003) Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 21: 409-413. (Pubitemid 36506632)
59. Higgins, P.G., Wisplinghoff, H., Stefanik, D., and Seifert, H. (2004) Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J Antimicrob Chemother 54: 821-823. (Pubitemid 39386738)
60. Hirai, K., Aoyama, H., Suzue, S., Irikura, T., Iyobe, S., and Mitsuhashi, S. (1986) Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother 30: 248-253. (Pubitemid 16038757)
61. Hu, X.E., Kim, N.K., Gray, J.L., Almstead, J.I.K., Seibel, W.L., and Ledoussal, B. (2003) Discovery of (3S)-Amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity against resistant pathogens. J Med Chem 46: 3655-3661. (Pubitemid 36988652)
62. Jacoby, G.A. (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 41: S120-S126.
63. Jacoby, G.A., Chow, N., and Waites, K.B. (2003) Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 47: 559-562.
64. Jalal, S., Ciofu, O., Hoiby, N., Gotoh, N., and Wretlind, B. (2000) Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44: 710-712. (Pubitemid 30117966)
65. Jellen-Ritter, A.S., and Kern, W.V. (2001) Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother 45: 1467-1472. (Pubitemid 32374119)
66. Jeong, J.Y., Yoon, H.J., and Kim, E.S. (2005) Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother 49: 2522-2524. (Pubitemid 40734495)
67. Jonas, D., Biehler, K., Hartung, D., Spitzmuller, B., and Daschner, F.D. (2005) Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob Agents Chemother 49: 773-775. (Pubitemid 40175693)
68. Kaatz, G.W., McAleese, F., and Seo, S.M. (2005a) Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother 49: 1857-1864. (Pubitemid 40631600)
69. Kaatz, G.W., Thyagarajan, R.V., and Seo, S.M. (2005b) Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob Agents Chemother 49: 161-169. (Pubitemid 40065788)
70. Kampranis, S.C., and Maxwell, A. (1996) Conversion of DNA gyrase into a conventional type II topoisomerase. Proc Natl Acad Sci USA 93: 14416-14421. (Pubitemid 26418981)
71. Kampranis, S.C., Bates, A.D., and Maxwell, A. (1999) A model for the mechanism of strand passage by DNA gyrase. Proc Natl Acad Sci USA 96: 8414-8419. (Pubitemid 29354805)
72. Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., and Suzuki, H. (1990) New topoisomerase essential for chromosome segregation in E. coli. Cell 63: 393-404. (Pubitemid 20355460)
73. Kern, W.V., Oethinger, M., Jellen-Ritter, A.S., and Levy, S.B. (2000) Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 44: 814-820. (Pubitemid 30165254)
74. Kim, O.K., and Ohemeng, K.A. (1998) Patents on DNA gyrase inhibitors: January 1995 to March 1998. Expert Opin Ther Pat 8: 959-969. (Pubitemid 28365527)
75. Kim, O.K., Barrett, J.F., and Ohemeng, K. (2001) Advances in DNA gyrase inhibitors. Exp Opin Invest Drugs 10: 199-212.
76. 2protein core. Biochemistry 19: 5229-5234.
77. Kohler, T., Michea-Hamzehpour, M., Henze, U., Gotoh, N., Curty, L.K., and Pechère, J.C. (1997) Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23: 345-354. (Pubitemid 27049187)
78. Kohler, T., Epp, S.F., Curty, L.K., and Pechère, J.C. (1999) Characterization of MexT, the regulator of the MexE-MexF-prN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 181: 6300-6305. (Pubitemid 29512938)
79. Koretke, K.K., Lupas, A.N., Warren, P.V., Rosenberg, M., and Brown, J.R. (2000) Evolution of two-component signal transduction. Mol Biol Evol 17: 1956-1970.
80. Koutsolioutsou, A., Martins, E.A., White, D.G., Levy, S.B., and Demple, B. (2001) A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar Typhimurium). Antimicrob Agents Chemother 45: 38-43. (Pubitemid 32039090)
81. Koutsolioutsou, A., Peña-Llopis, S., and Demple, B. (2005) Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates. Antimicrob Agents Chemother 49: 2746-2752. (Pubitemid 40917587)
82. Lesher, G.Y., Froelich, E.J., Gruett, M.D., Bailey, J.H., and Brundage, R.P. (1962) 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Chem 5: 1063-1065.
83. Levine, C., Hiasa, H., and Marians, K.J. (1998) DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim Biophys Acta-Gene Struct Expr 1400: 29-43. (Pubitemid 28475094)
84. Li, X.Z., Nikaido, H., and Poole, K. (1995) Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39: 1948-1953.
85. Li, X.Z., Barré, N., and Poole, K. (2000) Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother 46: 885-893. (Pubitemid 32000597)
86. Li, X.Z., Zhang, L., and Poole, K. (2002) SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 46: 333-343. (Pubitemid 34087177)
87. Li, Y., Mima, T., Komori, Y., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa. J Antimicrob Chemother 52: 572-575. (Pubitemid 37258415)
88. Lin, J., Michel, L.O., and Zhang, Q. (2002) CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother 46: 2124-2131. (Pubitemid 34665906)
89. Lin, J., Akiba, M., Sahin, O., and Zhang, Q. (2005) CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob Agents Chemother 49: 1067-1075. (Pubitemid 40327725)
90. Liu, L.F., andWang, J.C. (1978a) DNA-DNA gyrase complex: the wrapping of the DNA duplex outside the enzyme. Cell 15: 979-984.
91. Liu, L.F., and Wang, J.C. (1978b) Micrococcus luteus DNA gyrase: active components and a model for its supercoiling of DNA. Proc Natl Acad Sci USA 75: 2098-2102.
92. Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., and Plésiat, P. (2004) Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother 48: 1797-1802. (Pubitemid 38544391)
93. Lowe, M.N., and Lamb, H.M. (2000) Gemifloxacin. Drugs 59: 1137-1147.
94. Luo, N., Sahin, O., Lin, J., Michel, L.O., and Zhang, Q. (2003) In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother 47: 390-394. (Pubitemid 36070393)
95. Madurga, S., Sánchez-Céspedes, J., Belda, I., Vila, J., and Giralt, E. (2008) Binding mechanism of fluoroquinolone to the quinolone resistance-determining region of DNA Gyrase: towards an understanding of the molecular basis of quinolone resistance. Chem Bio Chem 9: 2081-2086.
96. Magnet, S., Courvalin, P., and Lambert, T. (2001) Resistance-nodulation- cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 45: 3375-3380. (Pubitemid 33107849)
97. Mammeri, H., Van De Loo, M., Poirel, L., Martinez-Martinez, L., and Nordmann, P. (2005) Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 49: 71-76. (Pubitemid 40065774)
98. Manjunatha, U.H., Dalal, M., Chatterji, M., Radha, D.R., Winweswariah, S.S., and Nagaraja, V. (2002) Functional characterization of mycobacterial DNA gyrase: an efficient decatenase. Nucleic Acids Res 30: 2144-2153. (Pubitemid 34567935)
99. Marchand, I., Damier-Piolle, L., Courvalin, P., and Lambert, T. (2004) Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 48: 3298-3304. (Pubitemid 39129322)
100. Markham, P.N., and Neyfakh, A.A. (2001) Efflux-mediated drug resistance in Gram-positive bacteria. Curr Opin Microbiol 4: 509-514. (Pubitemid 32964097)
101. Marrer, E., Schad, K., Satoh, A.T., Page, M.G.P., Johnson, M.M., and Piddock, L.J.V. (2006) Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae. Antimicrob Agents Chemother 50: 685-693. (Pubitemid 43190983)
102. Martin, R.G., and Rosner, J.L. (2002) Genomics of the marA/soxS/rob regulon of Escherichia coli: identification of directly activated promoters by application of molecular genetics and informatics to microarray data. Mol Microbiol 44: 1611-1624. (Pubitemid 34639437)
103. Martin, R.G., Gillette,W.K., Rhee, S., and Rosner, J.L. (1999) Structural requirements for marbox function in transcriptional activation of mar/sox/rob regulon promoters in Escherichia coli: sequence, orientation and spatial relationship to the core promoter. Mol Microbiol 34: 431-441. (Pubitemid 29507304)
104. Martínez-Martínez, L.A., Pascual, A., and Jacoby, G.A. (1998) Quinolone resistance from a transferable plasmid. Lancet 351: 797-799.
105. Martínez-Martínez, L., Pascual, A., Conejo, M.C., García, I., Joyanes, P., Doménech-Sánchez, A., and Benedí, V.J. (2002) Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum β-lactamase production. Antimicrob Agents Chemother 46: 3926-3932. (Pubitemid 35403270)
106. Maseda, H., Saito, K., Nakajima, A., and Nakae, T. (2000) Variation of the mexT gene, a regulator of the MexEF-OprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa. FEMS Microbiol Lett 192: 107-112. (Pubitemid 30748479)
107. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., and Nishino, T. (2000) Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44: 2242-2246. (Pubitemid 30650862)
108. Matsuo, Y., Eda, S., Gotoh, N., Yoshihara, E., and Nakae, T. (2004) MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol Lett 238: 23-28. (Pubitemid 39164526)
109. Maxwell, A. (1993) The interaction between coumarin drugs and DNA gyrase. Mol Microbiol 9: 681-686. (Pubitemid 23253494)
110. Mima, T., Sekiya, H., Mizushima, T.M., Kuroda, T., and Tsuchiya, T. (2005) Gene cloning and properties of the RND-type multidrug efflux pumps MexPQ-OpmE and MexMN-OprM from Pseudomonas aeruginosa. Microbiol Immunol 49: 999-1002. (Pubitemid 41687174)
111. Mine, T., Morita, Y., Kataoka, A., Mizushima, T., and Tsuchiya, T. (1999) Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother 43: 415-417. (Pubitemid 29079189)
112. Mizuno, T., Chou, M.Y., and Inouye, M. (1984) A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA). Proc Natl Acad Sci USA 81: 1966-1970. (Pubitemid 14146587)
113. Morita, Y., Cao, L., Gould, V.C., Avison, M.B., and Poole, K. (2006) nalD encodes a second repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa. J Bacteriol 188: 8649-8654. (Pubitemid 44894066)
114. Morrison, A., and Cozzarelli, N.R. (1979) Site-specific cleavage of DNA by E. coli DNA gyrase. Cell 17: 175-184. (Pubitemid 9188221)
115. Nakamura, S., Nakamura, M., Kojima, T., and Yoshida, H. (1989) gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother 33: 254-255. (Pubitemid 19053872)
116. Nazik, A., Poirel, L., and Nordmann, P. (2005) Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob Agents Chemother 49: 2146-2147. (Pubitemid 40631645)
117. Ng, E.Y.W., Trucksis, M., and Hooper, D.C. (1994) Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob Agents Chemother 38: 1345-1355. (Pubitemid 24170718)
118. Nikaido, H. (1996) Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 178: 5853-5859. (Pubitemid 26337766)
119. Nishino, K., and Yamaguchi, A. (2001) Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol 183: 5803-5812. (Pubitemid 32917397)
120. Nunoshiba, T., and Demple, B. (1994) A cluster of constitutive mutations affecting the C-terminus of the redox-sensitive SoxR transcriptional activator. Nucleic Acids Res 22: 2958-2962. (Pubitemid 24260621)
121. Oethinger, M., Podglajen, I., Kern, W.V., and Levy, S.B. (1998) Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother 42: 2089-2094. (Pubitemid 28363098)
122. Oethinger, M., Kern, W.V., Jellen-Ritter, A.S., McMurray, L.M., and Levy, S.B. (2000) Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 44: 10-13. (Pubitemid 30010664)
123. Ogawa, W., Koterasawa, M., Kuroda, T., and Tsuchiya, T. (2006) KmrA multidrug efflux pump from Klebsiella pneumoniae. Biol Pharm Bull 29: 550-553.
124. Oh, H., Stenhoff, J., Jalal, S., and Wretlind, B. (2003) Role of efflux pumps and mutations in genes for tompoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist 9: 323-328. (Pubitemid 38168187)
125. Okusu, H., Ma, D., and Nikaido, H. (1996) AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178: 306-308. (Pubitemid 26006095)
126. Olliver, A., Vallé, M., Chaslus-Dancla, E., and Cloeckaert, A. (2004) Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol Lett 238: 267-272. (Pubitemid 39164559)
127. Olliver, A., Vallé, M., Chaslus-Dancla, E., and Cloeckaert, A. (2005) Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob Agents Chemother 49: 289-301. (Pubitemid 40065805)
128. Ostrov, D.A., Hernández-Prada, J.A., Corsino, P.E., Finton, K.A., Le, N., and Rowe, T.C. (2007) Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother 51: 3688-3698. (Pubitemid 47519360)
129. Pan, X.S., and Fisher, L.M. (1999) Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrob Agents Chemother 43: 1129-1136. (Pubitemid 29214736)
130. Park, C.H., Robicsek, A., Jacoby, G.A., Sahm, D., and Hooper, D.C. (2006) prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50: 3953-3955. (Pubitemid 44684926)
131. Paton, J.H., and Reeves, D.S. (1988) Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. Drugs 36: 193-228. (Pubitemid 18215468)
132. Perry, C.M., Balfour, J.A.B., and Lamb, H.M. (1999) Gatifloxacin. Drugs 58: 683-696.
133. Piddock, L.J.V., White, D.G., Gensberg, K., Pumbwe, L., and Griggs, D. (2000) Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 44: 3118-3121. (Pubitemid 30803076)
134. Piddock, L.J.V., Johnson, M.M., Simjee, S., and Pumbwe, L. (2002) Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 46: 808-812. (Pubitemid 34157667)
135. Ping, Y., Ogawa, W., Kuroda, T., and Tsuchiya, T. (2007) Gene cloning and characterization of KdeA, a multidrug efflux pump from Klebsiella pneumoniae. Biol Pharm Bull 30: 1962-1964. (Pubitemid 47607773)
136. Pitout, J.D.D., Wei, Y., Church, D.L., and Gergson, D.B. (2008) Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6′)-Ib-cr. J Antimicrob Chemother 61: 999-1002.
137. Poirel, L., Liard, A., Rodriguez-Martínez, J.M., and Nordmann, P. (2005a) Vibrionaceae as a possible source of Qnr-like quinolone resistanse determinants. J Antimicrob Chemother 56: 1118-1121. (Pubitemid 43009831)
138. Poirel, L., Rodríguez-Martínez, J.M., Mammeri, H., Liard, A., and Nordmann, P. (2005b) Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 49: 3523-3525. (Pubitemid 41060609)
139. Pomposiello, P.J., and Demple, B. (2000) Identification of SoxS-regulated genes in Salmonella enterica serovar Typhimurium. J Bacteriol 182: 23-29. (Pubitemid 30004553)
140. Poole, K. (2000a) Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob Agents Chemother 44: 2233-2241. (Pubitemid 30650861)
141. Poole, K. (2000b) Efflux-mediated resistance to fluoroquinolones in Gram-positive bacteria and the mycobacteria. Antimicrob Agents Chemother 44: 2595-2599. (Pubitemid 30737668)
142. Poole, K., Krebes, K., McNally, C., and Neshat, S. (1993) Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175: 7363-7372. (Pubitemid 23339316)
143. Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., et
144. Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D.E., and Bianco, N. (1996b) Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother 40: 2021-2028. (Pubitemid 26296240)
145. Pumbwe, L., Randall, L.P., Woodward, M.J., and Piddock, L.J.V. (2004) Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibioticresistant Campylobacter jejuni. J Antimicrob Chemother 54: 341-347. (Pubitemid 39177451)
146. Ramos, J.L., Martínez-Bueno, M., Molina-Henares, A.J., Terán, W., Watanabe, K., Zhang, X., et al. (2005) The Tet R family of transcriptional repressors. Microbiol Mol Biol Rev 69: 325-356.
147. Reece, R.J., and Maxwell, A. (1991) The C-terminal domain of the Escherichia coli DNA gyrase A subunit is a DNA-binding protein. Nucleic Acids Res 19: 1399-1405. (Pubitemid 21913228)
148. Ribera, A., Doménech-Sánchez, A., Ruiz, J., Benedi, V.J., Jiménez de Anta, M.T., and Vila, J. (2002a) Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates. Microb Drug Resist 8: 2452-12451 (Pubitemid 36043689)
149. Ribera, A., Ruiz, J., Jimenez de Anta, M.T., and Vila, J. (2002b) Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother 49: 697-698. (Pubitemid 34428989)
150. Robicsek, A., Sahm, D.F., Strahilevitz, J., Jacoby, G.A., and Hooper, D.C. (2005) Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob Agents Chemother 49: 3001-3003. (Pubitemid 40917626)
151. Robicsek, A., Strahilevitz, J., Jacoby, G.A., Macielag, M., Abbanat, D., Park, C.H., et al. (2006) Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12: 83-88. (Pubitemid 43050081)
152. Ruiz, J., Casellas, S., Jimenez de Anta, M.T., and Vila, J. (1997) The region of the parE gene, homologous to the quinolone resistance-determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J Antimicrob Agents 39: 839-840. (Pubitemid 27296432)
153. Ruiz, J., Moreno, A., Jimenez de Anta, M.T., and Vila, J. (2005) A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates. Int J Antimicrob Agents 25: 542-545. (Pubitemid 40732611)
154. Ruthenburg, A.J., Graybosch, D.M., Huetsch, J.C., and Verdine, G.L. (2005) A superhelical spiral in the Escherichia coli DNA gyrase A C-terminal domain imparts unidirectional supercoiling bias. J Biol Chem 280: 26177-26184. (Pubitemid 41022213)
155. Sánchez-Céspedes, J., Blasco, M.D., Martí, S., Alba, V., Alcaide, E., Esteve, C., and Vila, J. (2008) Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate. Antimicrob Agents Chemothe 52: 2990-2991.
156. Sekiya, H., Mima, T., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) Functional cloning and characterization of a multidrug efflux pump, MexHI-OpmD, from a Pseudomonas aeruginosa mutant. Antimicrob Agents Chemother 47: 2990-2992. (Pubitemid 37040284)
157. Schneiders, T., Amyes, S.G.B., and Levy, S.B. (2003) Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 47: 2831-2837. (Pubitemid 37040255)
158. Schulz-Gasch, T., and Stahl, M. (2003) Binding site characteristics in structure-based virtual screening: evaluation of current docking tools. J Mol Model 9: 47-57. (Pubitemid 37240092)
159. Shen, L.L., Mitscher, L.A., Sharma, P.N., O'Donnell, T.J., Chu, D.W.T., Cooper, C.S., et al. (1989) Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry 28: 3886-3894. (Pubitemid 19125438)
160. Sierra, J.M., Marco, F., Ruiz, J., Jimenez de Anta, M.T., and Vila, J. (2002) Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus. Clin Microbiol Infect 8: 781-790. (Pubitemid 36054280)
161. Sierra, J.M., Martínez-Martínez, L., Vázquez, F., Giralt, E., and Vila, J. (2005a) Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum. Antimicrob Agents Chemother 49: 1714-1719. (Pubitemid 40631579)
162. Sierra, J.M., Cabeza, J.G., Ruiz, M., Montero, T., Hernandez, J., Mensa, J., et al. (2005b) The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae. Clin Microbiol Infect 11: 750-758. (Pubitemid 41167342)
163. Sobel, M.L., Hocquet, D., Cao, L., Plesiat, P., and Poole, K. (2005a) Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 49: 1782-1786. (Pubitemid 40631589)
164. Sobel, M.L., Neshat, S., and Poole, K. (2005b) Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa. J Bacteriol 187: 1246-1253. (Pubitemid 40299449)
165. Sorlozano, A., Gutierrez, J., Jiménez, A., de Dios Luna, J., and Martínez, J.L. (2007) Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-β-lactamase-producing Escherichia coli isolates. J Clin Microbiol 45: 2740-2742. (Pubitemid 47295520)
166. Stanhope, M.J., Walsh, S.L., Becker, J.A., Italia, M.J., Ingraham, K.A., Gwynn, M.N., et al. (2005) Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread. Antimicrob Agents Chemother 49: 4315-4326. (Pubitemid 41400979)
167. van der Straaten, T., Janssen, R., Mevius, D.J., and van Dissel, J.T. (2004) Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 48: 2292-2294. (Pubitemid 38691634)
168. Su, X.Z., Chen, J., Mizushima, T., Kuroda, T., and Tsuchiya, T. (2005) AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother 49: 4362-4364. (Pubitemid 41400988)
169. Suh, B., and Lorber, B. (1995) Quinolones. Med Clin North Am 79: 869-894.
170. Sulavik, M.C., Dazer, M., and Miller, P.F. (1997) The Salmonella Typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence. J Bacteriol 179: 1857-1866. (Pubitemid 27123066)
171. Sulavik, M.C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., et al. (2001) Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 45: 1126-1136. (Pubitemid 32230993)
172. Tavío, M.M., Vila, J., Ruiz, J., Ruiz, J., Martín- Sánchez, A.M., and Jiménez de Anta, M.T. (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli. J Antimicrob Chemother 44: 735-742.
173. Tran, J.H., and Jacoby, G.A. (2002) Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 99: 5638-5642.
174. Tran, J.H., Jacoby, G.A., and Hooper, D.C. (2005a) Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 49: 118-125. (Pubitemid 40065781)
175. Tran, J.H., Jacoby, G.A., and Hooper, D.C. (2005b) Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli topoisomerase IV. Antimicrob Agents Chemother 49: 3050-3052. (Pubitemid 40917639)
176. Truong-Bolduc, Q.C., and Hooper, D.C. (2007) The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and b-lactams in Staphylococcus aureus. J Bacteriol 189: 2996-3005. (Pubitemid 46697388)
177. Truong-Bolduc, Q.C., Zhang, X., and Hooper, D.C. (2003) Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J Bacteriol 185: 3127-3138. (Pubitemid 36539110)
178. Truong-Bolduc, Q.C., Dunman, P.M., Strahilevitz, J., Projan, S.J., and Hooper, D.C. (2005) MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 187: 2395-2405. (Pubitemid 40389138)
179. Truong-Bolduc, Q.C., Strahilevitz, J., and Hooper, D.C. (2006) NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob Agents Chemother 50: 1104-1107. (Pubitemid 43327822)
180. Valdezate, S., Vindel, A., Echeita, A., Baquero, F., and Cantó, R. (2002) Topoisomerase II and IV quinolone-resistance determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother 46: 665-671.
181. Valdezate, S., Vindel, A., Saéz-Nieto, J.A., Baquero, F., and Cantón, R. (2005) Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains. J Antimicrob Chemother 56: 220-223.
182. Vila, J. (2005) Fluoroquinolone resistance. In Frontiers in Antimicrobial Resístanse: A Tribute to Stuart B. Levy. White, D.G., Alekshun, M.N., and McDermott, P.F. (eds). Washington, DC, USA: ASM Press, pp. 41-52.
183. Vila, J., and Martínez, J.L. (2008) Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli: development of efflux pump inhibitors. Curr Drug Targ 9: 797-807.
184. Vila, J., Ruiz, J., Marco, F., Barceló, A., Goñi, P., Giralt, E., and Jiménez de Anta, M.T. (1994) Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother 38: 2477-2479.
185. Vila, J., Ruiz, J., Goñi, P., and Jiménez de Anta, M.T. (1996) Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 40: 491-493.
186. Vila, J., Martí, S., and Sánchez-Céspedes, J. (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59: 1210-1215. (Pubitemid 47073338)
187. Wang, J.C. (1998) Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine. Q Rev Biophys 31: 107-144. (Pubitemid 28448731)
188. Wang, J.C. (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3: 430-440. (Pubitemid 34685700)
189. Wang, M., Tran, J.H., Jacoby, G.A., Zhang, Y., Wang, F., and Hooper, D.C. (2003) Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47: 2242-2248. (Pubitemid 36753579)
190. Wang, M., Sahm, D.F., Jacoby, G.A., and Hooper, D.C. (2004) Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 48: 1295-1299. (Pubitemid 38405484)
191. Webber, M.A., and Piddock, L.V.J. (2001) Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother 45: 1550-1552. (Pubitemid 32374133)
192. Yamada, H., Kurose-Hamada, S., Fukuda, Y., Mitsuyama, J., Takahata, M., Minami, S., et al. (1997) Quinolone susceptibility of norA-disrupted Staphylococcus aureus. Antimicrob Agents Chemother 41: 2308-2309. (Pubitemid 27422237)
193. Yamada, Y., Hideka, K., Shiota, S., Kuroda, T., and Tsuchiya, T. (2006) Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus. Biol Pharm Bull 29: 554-556.
194. Yamane, K., Wachino, J., Suzuki, S., Kimura, K., Shibata, N., Kato, H., et al. (2007) New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51: 3354-3360. (Pubitemid 350067551)
195. Yamane, K., Wachino, J., Suzuki, S., and Arakawa, Y. (2008) Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 52: 1564-1566.
196. Yang, S., Clayton, S.R., and Zechiedrich, E.L. (2003) Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother 51: 545-556. (Pubitemid 36336146)
197. Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L.M., and Nakamura, S. (1991) Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother 35: 1647-1650.
198. Zgurskaya, H.I., and Nikaido, H. (2000) Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol 37: 219-225. (Pubitemid 30481007)
199. Zhanel, G.G., Ennis, K., Vercaigne, L., Walkty, A., Gin, A.S., Embil, J., et al. (2002) A critical review of the fluoroquinolones: focus on respiratory tract infections. Drugs 62: 13-59. (Pubitemid 34169425)
200. Zhao, Q., Li, X.Z., Srikumar, R., and Poole, K. (1998) Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB. Antimicrob Agents Chemother 42: 1682-1688. (Pubitemid 28311562)